Abstract: ObjectiveNeuroinflammation may disrupt neurotransmitter signaling. This study investigated whether gut microbiota-induced neuroinflammation can regulate glutamate pathways in bipolar disorder (BD).
MethodsFecal microbiota transplantation (FMT) was performed to observe behavioral changes in the antibiotic-treated C57BL/6J male mouse model of bipolar depression. Gut microbial structure, circulating, and prefrontal levels of inflammatory factors, microglial activation, and transcription levels of N-methyl-d-aspartate receptor (NMDAR) and α-amino-3-hydroxy-5-methyl-4 isoxazole receptor (AMPAR) genes were measured in the “BD” and control mice. Furthermore, the effects of interleukin-1 (IL-1) receptor antagonist (IL-1RA) on the glutamate pathways were assessed.
ResultsCompared with the control mice, “BD” mice displayed depression-like behaviors, with a lower diversity of gut bacteria and a decreased abundance of certain species. In addition, “BD” mice showed increased levels of inflammatory factors (e.g., IL-1β) in the serum and prefrontal cortex, microglial activation, and changes in the messenger RNA (mRNA) levels of NMDAR and AMPAR. Treatment with IL-1RA partially reversed the behavioral patterns, neuroinflammation, and transcription levels of glutamate receptors.
ConclusionsThe findings suggest that gut microbiota may influence glutamate receptor gene expression via an IL-1β-dependent pathway in a mouse model of BD, potentially contributing to neuroinflammatory mechanisms relevant to this disorder.

双相抑郁肠道菌群可通过IL-1β通路调节谷氨酸受体活性

[1]AndersonIM, HaddadPM, ScottJ, 2012. Bipolar disorder. BMJ, 345:e8508.

[2]ArgawAT, ZhangYT, SnyderBJ, et al., 2006. IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol, 177(8):5574-5584.

[3]ArifinWN, ZahiruddinWM, 2017. Sample size calculation in animal studies using resource equation approach. Malays J Med Sci, 24(5):101-105.

[4]BauerM, AndreassenOA, GeddesJR, et al., 2018. Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives. Lancet Psychiatry, 5(11):930-939.

[5]BellS, MaussionG, JefriM, et al., 2018. Disruption of GRIN2B impairs differentiation in human neurons. Stem Cell Rep, 11(1):183-196.

[6]BenedettiF, DallaspeziaS, MelloniEMT, et al., 2021. Effective antidepressant chronotherapeutics (sleep deprivation and light therapy) normalize the IL-1β:IL-1RA ratio in bipolar depression. Front Physiol, 12:740686.

[7]BeneytoM, Meador-WoodruffJH, 2008. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology, 33(9):2175-2186.

[8]BhattaraiY, WilliamsBB, BattaglioliEJ, et al., 2018. Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion. Cell Host Microbe, 23(6):775-785.e5.

[9]BluthéRM, DantzerR, KelleyKW, 1992. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res, 573(2):318-320.

[10]ChipmanPH, FetterRD, PanzeraLC, et al., 2022. NMDAR-dependent presynaptic homeostasis in adult hippocampus: synapse growth and cross-modal inhibitory plasticity. Neuron, 110(20):3302-3317.e7.

[11]CryanJF, ValentinoRJ, LuckiI, 2005. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev, 29(4-5):547-569.

[12]DaiCX, FuYY, LiXW, et al., 2025. Clinical efficacy and safety of vortioxetine as an adjuvant drug for patients with bipolar depression. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 26(1):26-38.

[13]DumanRS, SanacoraG, KrystalJH, 2019. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron, 102(1):75-90.

[14]EicherTP, MohajeriMH, 2022. Overlapping mechanisms of action of brain-active bacteria and bacterial metabolites in the pathogenesis of common brain diseases. Nutrients, 14(13):2661.

[15]ErnstJ, HockA, HenningA, et al., 2017. Increased pregenual anterior cingulate glucose and lactate concentrations in major depressive disorder. Mol Psychiatry, 22(1):113-119.

[16]GeorgeF, DanielC, ThomasM, et al., 2018. Occurrence and dynamism of lactic acid bacteria in distinct ecological niches: a multifaceted functional health perspective. Front Microbiol, 9:2899.

[17]GoldsmithDR, RapaportMH, MillerBJ, 2016. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry, 21(12):1696-1709.

[18]GoldsmithDR, BekhbatM, MehtaND, et al., 2023. Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology. Biol Psychiatry, 93(5):405-418.

[19]HardinghamGE, DoKQ, 2016. Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nat Rev Neurosci, 17(2):125-134.

[20]HaroonE, MillerAH, SanacoraG, 2017. Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology, 42(1):193-215.

[21]HuSH, LiA, HuangTT, et al., 2019. Gut microbiota changes in patients with bipolar depression. Adv Sci (Weinh), 6(14):1900752.

[22]JiangHY, LingZX, ZhangYH, et al., 2015. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun, 48:186-194.

[23]KangX, LiuCA, DingYQ, et al., 2023. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8⁺ T cells. Gut, 72(11):2112-2122.

[24]KleerebezemM, HolsP, BernardE, et al., 2010. The extracellular biology of the lactobacilli. FEMS Microbiol Rev, 34(2):199-230.

[25]KnueselT, MohajeriMH, 2021. The role of the gut microbiota in the development and progression of major depressive and bipolar disorder. Nutrients, 14(1):37.

[26]LiMX, HanL, XiaoJL, et al., 2023. IL-1RA treatment prevents chronic social defeat stress-induced depression-like behaviors and glutamatergic dysfunction via the upregulation of CREB-BDNF. J Affect Disord, 335:358-370.

[27]LiQQ, ChenJ, HuP, et al., 2022. Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory. Mol Psychiatry, 27(8):3468-3478.

[28]LiuML, FanGH, MengLK, et al., 2025. New perspectives on microbiome-dependent gut-brain pathways for the treatment of depression with gastrointestinal symptoms: from bench to bedside. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 26(1):1-25.

[29]LozanoCP, WilkensLR, ShvetsovYB, et al., 2022. Associations of the dietary inflammatory index with total adiposity and ectopic fat through the gut microbiota, LPS, and C-reactive protein in the Multiethnic Cohort-Adiposity Phenotype Study. Am J Clin Nutr, 115(5):1344-1356.

[30]LucidiL, PettorrusoM, VellanteF, et al., 2021. Gut microbiota and bipolar disorder: an overview on a novel biomarker for diagnosis and treatment. Int J Mol Sci, 22(7):3723.

[31]MaSS, ChenM, JiangYH, et al., 2023. Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb. Nature, 622(7984):802-809.

[32]MachielsK, JoossensM, SabinoJ, et al., 2014. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut, 63(8):1275-1283.

[33]Martinez-GurynK, HubertN, FrazierK, et al., 2018. Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids. Cell Host Microbe, 23(4):458-469.e5.

[34]McGuinnessAJ, DavisJA, DawsonSL, et al., 2022. A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia. Mol Psychiatry, 27(4):1920-1935.

[35]MuellerHT, Meador-WoodruffJH, 2004. NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder. Schizophr Res, 71(2-3):361-370.

[36]MurtaV, FaríasMI, PitossiFJ, et al., 2015. Chronic systemic IL-1β exacerbates central neuroinflammation independently of the blood-brain barrier integrity. J Neuroimmunol, 278:30-43.

[37]NakagawaY, ChibaK, 2015. Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol Ther, 154:21-35.

[38]NewpherTM, EhlersMD, 2008. Glutamate receptor dynamics in dendritic microdomains. Neuron, 58(4):472-497.

[39]NikolovaVL, SmithMRB, HallLJ, et al., 2021. Perturbations in gut microbiota composition in psychiatric disorders: a review and meta-analysis. JAMA Psychiatry, 78(12):1343-1354.

[40]Obi-AzuikeC, EbiaiR, GibsonT, et al., 2023. A systematic review on gut–brain axis aberrations in bipolar disorder and methods of balancing the gut microbiota. Brain Behav, 13(6):e3037.

[41]PainoldA, MörklS, KashoferK, et al., 2019. A step ahead: exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode. Bipolar Disord, 21(1):40-49.

[42]PolanskyO, SekelovaZ, FaldynovaM, et al., 2016. Important metabolic pathways and biological processes expressed by chicken cecal microbiota. Appl Environ Microbiol, 82(5):1569-1576.

[43]PolettiS, MazzaMG, CalesellaF, et al., 2021. Circulating inflammatory markers impact cognitive functions in bipolar depression. J Psychiatr Res, 140:110-116.

[44]RaoJS, HarryGJ, RapoportSI, et al., 2010. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry, 15(4):384-392.

[45]RenteriaR, MaierEY, BuskeTR, et al., 2017. Selective alterations of NMDAR function and plasticity in D1 and D2 medium spiny neurons in the nucleus accumbens shell following chronic intermittent ethanol exposure. Neuropharmacology, 112:164-171.

[46]SharonG, SampsonTR, GeschwindDH, et al., 2016. The central nervous system and the gut microbiome. Cell, 167(4):915-932.

[47]ShenW, WangQW, LiuYN, et al., 2020. Synaptotagmin-7 is a key factor for bipolar-like behavioral abnormalities in mice. Proc Natl Acad Sci USA, 117(8):4392-4399.

[48]ShenZH, LuoWW, TanB, et al., 2022. Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn’s disease. eBioMedicine, 85:104285.

[49]SmithBJ, MillerRA, SchmidtTM, 2021. Muribaculaceae genomes assembled from metagenomes suggest genetic drivers of differential response to acarbose treatment in mice. mSphere, 6(6):e00851-21.

[50]SongWD, WangYY, LiGC, et al., 2023. Modulating the gut microbiota is involved in the effect of low-molecular-weight Glycyrrhiza polysaccharide on immune function. Gut Microbes, 15(2):2276814.

[51]SpulberS, BartfaiT, SchultzbergM, 2009. IL-1/IL-1ra balance in the brain revisited – evidence from transgenic mouse models. Brain Behav Immun, 23(5):573-579.

[52]StrennN, PålssonE, LibergB, et al., 2021. Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls. Psychiatry Res, 296:113606.

[53]SubletteME, CheungS, LiebermanE, et al., 2021. Bipolar disorder and the gut microbiome: a systematic review. Bipolar Disord, 23(6):544-564.

[54]TraynelisSF, WollmuthLP, McBainCJ, et al., 2010. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev, 62(3):405-496.

[55]van VugtB, van KerkoerleT, VartakD, et al., 2020. The contribution of AMPA and NMDA receptors to persistent firing in the dorsolateral prefrontal cortex in working memory. J Neurosci, 40(12):2458-2470.

[56]VerseleR, SevinE, GosseletF, et al., 2022. TNF-α and IL-1β modulate blood-brain barrier permeability and decrease amyloid-β peptide efflux in a human blood-brain barrier model. Int J Mol Sci, 23(18):10235.

[57]WangQW, WangYH, WangB, et al., 2021. Synaptotagmin-7–mediated activation of spontaneous NMDAR currents is disrupted in bipolar disorder susceptibility variants. PLoS Biol, 19(7):e3001323.

[58]WangXY, SunGQ, FengT, et al., 2019. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res, 29(10):787-803.

[59]WangZ, ChenWH, LiSX, et al., 2021. Gut microbiota modulates the inflammatory response and cognitive impairment induced by sleep deprivation. Mol Psychiatry, 26(11):6277-6292.

[60]WongML, InserraA, LewisMD, et al., 2016. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry, 21(6):797-805.

[61]WuWL, GongXX, QinZH, et al., 2025. Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases—an update. Acta Pharmacol Sin, 46:3129-3142.

[62]XuHT, FangF, WuKZ, et al., 2023. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Microbiome, 11:262.

[63]XuYW, YeLY, LiZS, et al., 2025. Microglial transient receptor potential melastatin 2 deficiency accelerates seizure development via increasing AMPAR-mediated neuronal excitability. MedComm, 6(8):e70271.

[64]Yamada-FowlerN, FredriksonM, SöderkvistP, 2014. Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson’s disease in swedish population. PLoS ONE, 9(6):e99294.

[65]YaoH, ZhangDL, YuH, et al., 2023. Gut microbiota regulates chronic ethanol exposure-induced depressive-like behavior through hippocampal NLRP3-mediated neuroinflammation. Mol Psychiatry, 28(2):919-930.

[66]ZhangGX, MaFM, ZhangZW, et al., 2023. Associated long-term effects of decabromodiphenyl ethane on the gut microbial profiles and metabolic homeostasis in sprague-dawley rat offspring. Environ Int, 172:107802.

[67]ZhaoQ, HaoY, YangXQ, et al., 2023. Mitigation of maternal fecal microbiota transplantation on neurobehavioral deficits of offspring rats prenatally exposed to arsenic: role of microbiota-gut-brain axis. J Hazard Mater, 457:131816.

[68]ZhuHZ, LiangYD, MaQY, et al., 2019. Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota. Biomed Pharmacother, 112:108621.